This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,226.36 firm-fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension in 180 ml bottles, with a completion date of November 6, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
The contract award reviewed was not designated with any set-aside requirements, indicating open competition. The DLA, as a defense agency, is responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces, other federal agencies, and partner nations.
Generated 2/4/25, 10:25 AM